retatrutide type 2 diabetes phase 2 trial results 2024 2: Weight Loss and Key Findings – Bolt Pharmacy Retatrutide Results: 28.3% Weight Loss
Description
These shifts can make it easier to slip back into old habits and harder to maintain weight loss

Hypotheses include medication-induced delayed gastric emptying, small intestinal bacterial overgrowth, and dietary sulfur load, but direct evidence is lacking

[1] These are included in treatment plans when necessary, but the specific options arent listed publicly, and my attempts to confirm details went unanswered

The results revealed that 180 patients developed acute pancreatitis and 108 patients developed pancreatic cancer
Weight loss slowdowns are common with GLP-1 therapy and do not always require dose increases

Some changes are visible in 1 month, while for others, it could take about 3 months
